Intravitreal therapy for diabetic macular edema: an update

C Furino, F Boscia, M Reibaldi… - Journal of …, 2021 - Wiley Online Library
Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite
that DME represents a sight‐threatening condition, it is also among the most accessible to …

[HTML][HTML] Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence

RM Hanna, M Barsoum, F Arman, U Selamet… - Kidney international, 2019 - Elsevier
Vascular endothelial growth factor (VEGF) inhibitors have emerged as powerful tools to treat
malignant neoplasms and ocular diseases by virtue of their ability to inhibit angiogenesis …

Thrombotic microangiopathy and acute kidney injury induced after intravitreal injection of vascular endothelial growth factor inhibitors VEGF blockade-related TMA …

RM Hanna, NT Tran, SS Patel, J Hou… - Frontiers in …, 2020 - frontiersin.org
Vascular endothelial growth factor (VEGF) inhibition can cause worsening hypertension,
proteinuria, chronic kidney injury, and glomerular disease. Thrombotic microangiopathy …

Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy

M Shye, RM Hanna, SS Patel, N Tram-Tran… - Clinical Kidney …, 2020 - academic.oup.com
Systemic vascular endothelial growth factor (VEGF) inhibitions can induce worsening
hypertension, proteinuria and glomerular diseases of various types. These agents can also …

Pharmacokinetic study of intravitreal aflibercept in humans with neovascular age-related macular degeneration

DV Do, W Rhoades, QD Nguyen - Retina, 2020 - journals.lww.com
Purpose: To investigate the half-life of aflibercept in aqueous humor after a single intravitreal
injection in patients with neovascular age-related macular degeneration. Methods …

Long-term change in renal function after intravitreal anti-vegf treatment for diabetic macular edema: a 2-year retrospective cohort study

YC Fang, IP Lai, TT Lai, TC Chen, CH Yang… - Ophthalmology and …, 2023 - Springer
Introduction To investigate the longitudinal changes in renal function and associated factors
after intravitreal anti-vascular endothelial growth factor (VEGF) administration in diabetic …

Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab

RM Hanna, L Abdelnour, H Hasnain… - … Open Medical Case …, 2020 - journals.sagepub.com
Certain diabetic and hypertensive patients started on intravitreal vascular endothelial growth
factor inhibition for diabetic retinopathy may experience worsening of hypertension and …

Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes

M Sugimoto, C Handa, K Hirano, T Sunaya… - Graefe's Archive for …, 2022 - Springer
Purpose To report the safety and effectiveness of intravitreal aflibercept (IVT-AFL) for
diabetic macular edema (DME) in the real-world clinical practice setting in Japan. Methods …

Comparison of macular thickness measurements using swept-source and spectral-domain optical coherence tomography in healthy and diabetic subjects

K **ong, X Gong, W Li, L Yuting, J Meng… - Current Eye …, 2021 - Taylor & Francis
Purpose: To establish normative data for macular thickness in Chinese aged 30 to 80 years
using the swept-source optical coherence tomography (SS-OCT) device. Methods: The …

[PDF][PDF] Clinical application of optical coherence tomography angiography in diabetic macular edema

M Lv, T Li, Y Li - African Health Sciences, 2023 - ajol.info
Clinical application of optical coherence tomography angiography in diabetic macular edema
Page 1 Clinical application of optical coherence tomography angiography in diabetic macular …